VIVE's free cash flow for Q3 2022 was $-3.54M. For the 2022 fiscal year, VIVE's free cash flow was decreased by $2.67M and operating cash flow was $-3.35M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Operating Cash Flow	$ -16.23M	$ -12.89M	$ -15.24M	$ -31.24M	$ -43.09M	$ -34.85M
Investing Cash Flow	$ -595.00K	$ -456.00K	$ -781.00K	$ -1.09M	$ -2.14M	$ -3.40M
Financing Cash Flow	$ 69.00K	$ 26.04M	$ 9.76M	$ 16.11M	$ 54.02M	$ 50.90M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 49.33M	$ 19.22M	$ 7.05M	$ 13.31M	$ 29.52M	$ 20.73M
Income Tax Paid Supplemental Data	-	-	-	$ 0.00	$ 2.00K	$ 0.00
Interest Paid Supplemental Data	-	-	-	$ 2.51M	$ 2.67M	$ 2.07M
Issuance Of Capital Stock	$ 32.00K	$ 25.86M	$ 341.00K	$ 16.27M	$ 53.79M	$ 31.57M
Issuance Of Debt	-	-	$ 1.34M	$ 0.00	$ 0.00	$ 29.21M
Repayment Of Debt	-	-	-	-	$ 0.00	$ -10.00M
Free Cash Flow	$ -16.83M	$ -13.35M	$ -16.02M	$ -32.32M	$ -45.23M	$ -35.76M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Viveve Medical Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing